Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GRANISETRON Cause Thrombocytopenia? 37 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Thrombocytopenia have been filed in association with GRANISETRON (Granisetron Hydrochloride). This represents 1.5% of all adverse event reports for GRANISETRON.

37
Reports of Thrombocytopenia with GRANISETRON
1.5%
of all GRANISETRON reports
5
Deaths
12
Hospitalizations

How Dangerous Is Thrombocytopenia From GRANISETRON?

Of the 37 reports, 5 (13.5%) resulted in death, 12 (32.4%) required hospitalization, and 10 (27.0%) were considered life-threatening.

Is Thrombocytopenia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GRANISETRON. However, 37 reports have been filed with the FAERS database.

What Other Side Effects Does GRANISETRON Cause?

Nausea (433) Product adhesion issue (395) Death (319) Vomiting (185) Drug ineffective (177) Wrong technique in product usage process (172) Constipation (129) Inappropriate schedule of drug administration (115) No adverse event (111) Product use in unapproved indication (103)

What Other Drugs Cause Thrombocytopenia?

DEXAMETHASONE (5,873) RITUXIMAB (4,810) CYCLOPHOSPHAMIDE (4,669) LENALIDOMIDE (4,584) CARBOPLATIN (4,483) METHOTREXATE (3,865) DOXORUBICIN (3,638) ETOPOSIDE (3,085) VINCRISTINE (2,940) OXALIPLATIN (2,886)

Which GRANISETRON Alternatives Have Lower Thrombocytopenia Risk?

GRANISETRON vs GRANULOCYTE COLONY-STIMULATING FACTOR NOS GRANISETRON vs GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GRANISETRON vs GRAZOPREVIR GRANISETRON vs GRISEOFULVIN GRANISETRON vs GUAIFENESIN

Related Pages

GRANISETRON Full Profile All Thrombocytopenia Reports All Drugs Causing Thrombocytopenia GRANISETRON Demographics